Nanobiotix Reports H1 GAAP EPS Loss of €0.70 and €5.6M in Revenue

Key Facts

1Nanobiotix reported a GAAP EPS loss of €0.70.

2The company reported revenue of €5.6M for the period.

Nanobiotix reported a GAAP EPS loss of €0.70 for the first half of 2026. Seeking Alpha reported that the company generated revenue of €5.6M during the period, according to the company's financial statements.

NBTX closed at $35.24 on September 23, 2026, with the stock trading between a low of $34.73 and a high of $36.1 during that session. These results come as the company manages its financial resources to ensure the continuation of its core operations.